Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Marek Sochor"'
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 10, p 2116 (2017)
Oncogenic microRNAs (oncomiRs) accumulate in serum due to their increased stability and thus serve as biomarkers in breast cancer (BC) pathogenesis. Four oncogenic microRNAs (miR-155, miR-19a, miR-181b, and miR-24) and one tumor suppressor microRNA (
Externí odkaz:
https://doaj.org/article/58b4905befea457390e2117f8cb350e7
Autor:
Jana Mergancová, Anna Lierová, Oldřich Coufal, Jan Žatecký, Bohuslav Melichar, Ilona Zedníková, Jindřiška Mergancová, Anna Jesenková, Karel Šťastný, Jiří Gatěk, Otakar Kubala, Jiří Prokop, Daniel Dyttert, Marián Karaba, Ivana Schwarzbacherová, Anna Humeňanská, Jindřich Šuk, Michal Valenta, Vladimír Moucha, Lukáš Sákra, Aleš Hlávka, Mária Hácová, Radovan Vojtíšek, Marek Sochor, Tomáš Jirásek, Michaela Zábojníková, Martina Zemanová, Katarína Macháleková, Dominika Rusnáková, Eva Kúdelová, Marek Smolár
Publikováno v:
Surgical Oncology. 41:101726
Radiation-associated angiosarcoma (RAAS) is a rare and serious complication of breast irradiation. Due to the rarity of the condition, clinical experience is limited and publications on this topic include only retrospective studies or case reports.Al
Autor:
Marek, Sochor
Publikováno v:
Casopis lekaru ceskych. 157(1)
Palliative care has evolved in the last half a century from a philosophy of care aiming at care of dying patients to specific/standalone medical specialization caring of patients with incurable diseases. Patients with advanced cancer suffer from phys
Publikováno v:
International Journal of Molecular Sciences; Volume 18; Issue 10; Pages: 2116
Oncogenic microRNAs (oncomiRs) accumulate in serum due to their increased stability and thus serve as biomarkers in breast cancer (BC) pathogenesis. Four oncogenic microRNAs (miR-155, miR-19a, miR-181b, and miR-24) and one tumor suppressor microRNA (
Publikováno v:
European Journal of Cancer. 92:S121
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 28(3)
Patients with advanced cancer experience a significant number of physical symptoms and psychological distress, which worsen their quality of life (QOL). Palliative care is oriented to prevent and relieve suffering and promote QOL of patients with adv
Publikováno v:
Journal of Clinical Oncology. 35:e23021-e23021
e23021 Background: Early breast cancer is a frequent female disease with different outcomes. New approaches are needed in order to improve its prognosis. MicroRNAs (miRs) are modulators of gene expression and act as oncogenes and function to inhibit
Autor:
Marek Sochor
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 26(5)
Background Patients with cancer are highly susceptible to infections. There is a lack of evidencebased guidelines or protocols for their management in palliative and endoflife care. Purpose To define an optimal dia-gnostic approach and therapeutic ma
Autor:
Pavel Chlebus, Marek Sochor
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 26(2)
Breast cancer incidence is 120/100,000 women and thus, it is the most frequent malignant disease in women. Despite the ever-increasing incidence, mortality has stayed stable; this is due to screening with detection of early breast cancers, adjuvant t
Publikováno v:
Journal of Clinical Oncology. 32:e20546-e20546
e20546 Background: Patients with advanced cancer experience symptoms that worsen quality of life (QoL). Palliative care (PC) is traditionally applied after antineoplastic therapy. A concept of earl...